Recruiting Huntingtons Disease Studies in New Orleans
Efficacy, Safety & Pharmacokinetic (PK) Study of HLD200 in Children Aged 4-5 Years with ADHD
This study will evaluate the efficacy, safety and pharmacokinetics of HLD200 (20 mg and 40 mg) in children aged 4 to 5 years with ADHD....
Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD
To evaluate the efficacy and safety of NRCT-101SR compared to placebo in subjects 13-17 years of age with ADHD...
About Huntingtons Disease Clinical Trials in New Orleans
Huntington's disease is an inherited condition that causes progressive degeneration of nerve cells in the brain, affecting movement, cognition, and behavior. It is caused by a mutation in the HTT gene. Current treatments manage symptoms, while gene-silencing therapies are being studied.
There are currently 2 huntingtons disease clinical trials recruiting participants in New Orleans, LOUISIANA. These studies are seeking a combined 328 participants. Research is being sponsored by Ironshore Pharmaceuticals and Development, Inc, Neurocentria, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Huntingtons Disease Clinical Trials in New Orleans — FAQ
Are there huntingtons disease clinical trials in New Orleans?
Yes, there are 2 huntingtons disease clinical trials currently recruiting in New Orleans, LOUISIANA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Orleans?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.
Are clinical trials in New Orleans free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.
What huntingtons disease treatments are being tested?
The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for huntingtons disease.
Data updated March 2, 2026 from ClinicalTrials.gov